Harnessing the power of biomedical data 
to bridge the gap

between clinical research and clinical care

 
 
HomeHero.jpg
 

 

Informed Decisions.

Better Outcomes.

Participation in clinical trial research by community-based oncology practices is necessary to advance the development of innovative, molecularly-targeted cancer therapies. However, complex trial designs and nuanced biomarker requirements, together with limited access to actionable information, create new challenges for practices that want to bring novel therapeutics to their community via clinical research. Our mission at Genospace is to bridge this gap between clinical research and clinical care through developing technology and services that enable the delivery of personalized medicine at scale.

 
websitegraphic11.png
 

Clinical Trial Matching & Menu Management

Highly-specific trial matching incorporating clinical-genomic patient data alerts providers of patients eligible for a study at their office currently open to enrollment. Increase accruals for your site with Genospace Trial Match.

EMR-to-EDC
(E2E) Integration

Data captured in your site's source EMR system is automatically transferred to a clinical trial database without any intervention from a data coordinator to trigger the transfer. Save time for your site with Genospace E2E.

Study Feasibility
& Site Selection

Evaluate your site's enrollment potential for a new study opportunity by assessing past enrollment rates, competing trials, and other population measures. Make data-driven assessments with Genospace Feasibility.

grey.jpg
 
 

Genospace is the precision medicine platform for Sarah Cannon Research Institute (SCRI) which includes more than 250 locations and…

 
 
 

4,500+

registered patients participating in trials yearly

1 in 5

patients with cancer treated by SCRI and its affiliated sites

~700

first-in-human clinical trials conducted to date

 
 
 
 
map.png

"Oncologists call routinely to ask for guidance about comprehensive genomic profiling results. Genospace provides real-time actionable information and connects clinicians to our expert team of personalized medicine scientists. Genospace is paving a new way forward in clinical research and clinical care."

- Dr. David Spigel, Chief Scientific Officer, SCRI

Screenshot 2023-08-07 at 12.10.21 PM.png
 
 

Want to Make a Difference?

 
 

Join a team where data science, software engineering, and creative design intersect to power precision medicine

 
 
joinus.jpg